Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factorsTomoyuki Igarashi, Yataro Daigo, Koji Teramoto et al.|ESMO Open|2016Cited by 80
Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancerKoji Teramoto, Yataro Daigo, Yoko Kataoka et al.|Lung Cancer|2019Cited by 59
Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancerKoji Teramoto, Yataro Daigo, Mitsuaki Ishida et al.|Cancer Immunology Immunotherapy|2020Cited by 12
Prognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancerKoji Teramoto, Yataro Daigo, Tomoyuki Igarashi et al.|Cancer Immunology Immunotherapy|2023Cited by 11
Oncogenic epidermal growth factor receptor signal-induced histone deacetylation suppresses chemokine gene expression in human lung adenocarcinomaHidetoshi Sumimoto, Yataro Daigo, Atsushi Takano et al.|Scientific Reports|2023Cited by 10